The New Jersey Supreme Court ruled on August 22 that consumers’ state-law claims that manufacturers of a generic Reglan, a heartburn medication, did not adequately warn about its risks are not ...
The U.S. Supreme Court is asking the Obama administration for its views on whether generic drug companies can be sued over allegations that they inadequately labeled their products. A number of ...
The Supreme Court on Thursday ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the ...
(CN) - Generic drug manufacturers will not have to face claims that they failed to warn consumers about harmful side effects associated with their products, the Supreme Court ruled Thursday, finding ...
Responding to a federal court question, the Alabama Supreme Court ruled that a man who claims he was injured by a generic version of Pfizer’s Reglan can sue the innovator company for not properly ...
(CN) - A woman who claims she was harmed by a generic form of Reglan can sue the manufacturer of the name-brand acid-reflux drug, but not the producers of generic versions, a California appeals court ...
> Roche is planning to hold a European roadshow next week for a bond issue to help the Swiss drugmaker fund its planned buyout of Genentech, Reuters reported, citing three sources familiar with the ...
The Supreme Court on Thursday ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the ...
Late last month, the Food and Drug Administration ruled that makers of the drug metoclopramide must put the strongest so-called black-box warning on the product’s package insert. Also sold as Reglan, ...
. Researchers showed that women in their first trimester can safely use metoclopramide without risk of birth defects. Nausea plagues most women in the first three months of pregnancy. Although ...
MONTGOMERY, Ala. (AP) — Brand-name drug makers can be held liable for warnings on a generic medication even if it was produced by another company, the Alabama Supreme Court ruled Friday, standing by ...